{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:13:59Z","timestamp":1794323639603,"version":"4.9.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2015,3,4]]},"DOI":"10.3111\/13696998.2014.985788","type":"journal-article","created":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T06:54:42Z","timestamp":1416380082000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["An analysis of the cost-effectiveness of starting insulin detemir in insulin-na\u00efve people with type 2 diabetes"],"prefix":"10.3111","volume":"18","author":[{"given":"Philip","family":"Home","sequence":"first","affiliation":[{"name":"aThe Medical School, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Hyun","family":"Baik","sequence":"additional","affiliation":[{"name":",","place":["South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Gonz\u00e1lez","family":"G\u00e1lvez","sequence":"additional","affiliation":[{"name":"cInstituto Jalisciense de Investigaci\u00f3n en Diabetes y Obesidad, Guadalajara, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Malek","sequence":"additional","affiliation":[{"name":"dInternal Medicine Department, University Hospital Setif, Setif, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Nikolajsen","sequence":"additional","affiliation":[{"name":"eMarket Access \u2013 Value Communication, Novo Nordisk A\/S, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,11,21]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"International Diabetes Federation. Brussels Belgium: IDF. Last updated 2012. IDF Diabetes Atlas Update. 2012. http:\/\/www.idf.org\/diabetesatlas"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.029"},{"key":"e_1_3_3_4_1","first-page":"455","article-title":"Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study","volume":"57","author":"Calvert MJ","year":"2007","unstructured":"Calvert MJ, McManus RJ, Freemantle N. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract 2007;57:455-60","journal-title":"Br J Gen Pract"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00674.x"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.021"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02002.x"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02176.x"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-9-19"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02098.x"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP13176.CSUPPL"},{"key":"e_1_3_3_12_1","unstructured":"International Diabetes Federation. Global guideline for type 2 diabetes. 2012. Brussels Belgium: IDF. http:\/\/www.idf.org\/global-guideline-type-2-diabetes-2012. Accessed January 3 2013"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2534-0"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-1365"},{"key":"e_1_3_3_15_1","first-page":"192","article-title":"Efficacia e sicurezza di detemir vs glargine in aggiunta a metformina e repaglinide in pazienti con diabete mellito di tipo 2 non adeguatamente controllati dagli ipoglicemizzanti orali","volume":"31","author":"Papa G","year":"2011","unstructured":"Papa G, Degano C, Iurato P, et al. Efficacia e sicurezza di detemir vs glargine in aggiunta a metformina e repaglinide in pazienti con diabete mellito di tipo 2 non adeguatamente controllati dagli ipoglicemizzanti orali. G It Diabetol Metab 2011;31:192-8","journal-title":"G It Diabetol Metab"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.10.020"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.11.3080"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0911-x"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0132-0"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01715.x"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03329.x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2006.00674.x"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2007.0265"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X242755"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(10)70004-8"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.020"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.03.968"},{"key":"e_1_3_3_28_1","first-page":"A662","article-title":"Estimating the direct medical costs associated with diabetes mellitus-related complications in Indonesia","volume":"15","author":"Todorova L","year":"2012","unstructured":"Todorova L, Hnoosh A, Bloomfield E, et al. Estimating the direct medical costs associated with diabetes mellitus-related complications in Indonesia. Value Health 2012;15:A662","journal-title":"Value Health"},{"key":"e_1_3_3_29_1","first-page":"A662","article-title":"Direct medical costs of diabetes mellitus-related complications in India","volume":"15","author":"Todorova L","year":"2012","unstructured":"Todorova L, Hnoosh A, Korde G, et al. Direct medical costs of diabetes mellitus-related complications in India. Value Health 2012;15:A662","journal-title":"Value Health"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.03.969"},{"key":"e_1_3_3_31_1","unstructured":"World Health Organization. WHO Mortality Database. 2012. Geneva Switzerland: WHO. http:\/\/www.who.int\/healthinfo\/mortality_data\/en\/. Accessed January 3 2014"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X1980"},{"key":"e_1_3_3_33_1","unstructured":"The World Bank. World Bank Open Data. 2012. Washington D.C USA: The World Bank Group. http:\/\/data.worldbank.org\/. Accessed January 4 2014"},{"key":"e_1_3_3_34_1","unstructured":"World Health Organization. Choosing interventions that are cost effective. 2013. Geneva Switzerland: WHO. http:\/\/www.who.int\/choice\/en\/. Accessed January 4 2014"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2215"},{"issue":"1","key":"e_1_3_3_36_1","first-page":"S380","article-title":"Beginning insulin in people with type 2 diabetes mellitus in real-life practice - 1 -year results of the 4-year CREDIT study","volume":"53","author":"Home P","year":"2010","unstructured":"Home P, Balkau BJ, Danchin N, et al. Beginning insulin in people with type 2 diabetes mellitus in real-life practice - 1 -year results of the 4-year CREDIT study. Diabetologia 2010;53(1 Suppl):S380","journal-title":"Diabetologia"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02849895"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0069-z"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.05.022"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.4236\/ojepi.2012.22009"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2070"},{"key":"e_1_3_3_42_1","first-page":"4","article-title":"Chronic diabetic complications in Africa","volume":"19","author":"Tesfaye S","year":"2011","unstructured":"Tesfaye S, Gill G. Chronic diabetic complications in Africa. Afr J Diabetes Med 2011;19:4-8","journal-title":"Afr J Diabetes Med"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.05.009"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3111\/13696998.2014.985788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:42:21Z","timestamp":1770392541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3111\/13696998.2014.985788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,21]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3,4]]}},"alternative-id":["10.3111\/13696998.2014.985788"],"URL":"https:\/\/doi.org\/10.3111\/13696998.2014.985788","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-11-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}